PENTAMBODY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PENTAMBODY Trademark

Serial Number: 79225073 • Registration: 5899437

PENTAMBODY is a trademark filed by BEIJING HANMI PHARMACEUTICAL CO., LTD. on June 29, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BEIJING HANMI PHARMACEUTICAL CO., LTD.

No.10 Tianzhu West Road
Beijing , CN

Entity Type: 16

Trademark Details

Filing Date

June 29, 2017

Registration Date

November 5, 2019

Published for Opposition

August 20, 2019

Goods & Services

Medicines for human purposes, pharmaceutical preparations, drugs for medical purposes, biological preparations for medical purposes, biochemical drugs, and pharmaceutical preparations in the form of injection, each of which being, namely, for treating one or more of autoimmune diseases, immune response against grafts, allergic reactions, neurodegenerative diseases, neoplastic diseases and cellular proliferative disorders, arthritis, rheumatoid arthritis, psoriasis, multiple sclerosis (MS), ulcerative colitis, Crohn's disease, systemic lupus erythematosus (SLE), glomerulonephritis, dilated cardiomyopathy-like diseases, Sjogren's syndrome, allergic contact dermatitis, polymyositis, scleroderma, periarteritis nodosa, rheumatic fever, vitiligo, insulin-dependent diabetes mellitus, Behcet's syndrome, chronic thyroiditis, Parkinson's disease, Huntington's disease, Machado-Joseph disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt - Jakob disease, leukemia, lymphoma, myeloma, brain tumors, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), nasopharyngeal cancer, esophageal cancer, stomach cancer, pancreatic cancer, gallbladder cancer, liver cancer, colorectal cancer, breast cancer, ovarian cancer, cervical cancer, endometrial cancer, uterine sarcoma, prostate cancer, bladder cancer, renal cell carcinoma, melanoma, and combinations thereof; nutritional supplements and dietetic substances adapted for medical use, namely, dietetic foods adapted for medical use and dietetic beverages adapted for medical use

Filing History

TEAS SECTION 71 RECEIVED
Apr 30, 2026 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 5, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2020 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 2, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 2, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 31, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2019 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 5, 2019 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2019 CRFA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 19, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 19, 2019 OPNR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 17, 2019 ERFR
EX PARTE APPEAL-INSTITUTED
Jun 17, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 17, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jun 17, 2019 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 17, 2018 GNFN
FINAL REFUSAL E-MAILED
Dec 17, 2018 GNFR
FINAL REFUSAL WRITTEN
Dec 17, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2018 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 14, 2018 CHAN
ASSIGNED TO LIE
Nov 9, 2018 ALIE
NOTICE OF REVIVAL - MAILED
Oct 31, 2018 NREV
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 30, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 30, 2018 TROA
PETITION TO REVIVE-GRANTED
Oct 30, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 30, 2018 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 1, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 1, 2018 ABN2
REFUSAL PROCESSED BY IB
Feb 24, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2018 RFCS
REFUSAL PROCESSED BY MPU
Feb 2, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 29, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jan 28, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 23, 2018 MAFR
ASSIGNED TO EXAMINER
Jan 19, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 18, 2018 REPR